Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC
Clinical trial NCT05213312 · UNKNOWN
Trial details
- NCT number
- NCT05213312
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2022-11-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.